Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses.
Naveen C Srivastav, Neeraj Shakya, Michelle Mak, Chao Liang, D Lorne J Tyrrell, Babita Agrawal, Rakesh Kumar, Naveen C. Srivastav, Neeraj Shakya, Michelle Mak, Chao Liang, D. Lorne J. Tyrrell, Babita Agrawal, Rakesh Kumar
文献索引:Bioorg. Med. Chem. 18(21) , 7542-7, (2010)
全文:HTML全文
摘要
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) lead to serious liver diseases worldwide. Co-infection with HBV and HCV is very common and is associated with increased risk of liver pathogenesis, liver cancer, and liver failure. Several 5-substituted 3'-fluoro (or chloro) (1-4, 6, 7, 17-19) and 2',3'-difluoro 2',3'-dideoxynucleosides (15 and 16) were synthesized and evaluated for in vitro antiviral activities against duck hepatitis B virus (DHBV), human hepatitis B virus, and hepatitis C virus. Of these compounds 4, 7, 17, and 19 demonstrated moderate anti-HBV activity, and 2, 4, 7, 8, and 19 were weak inhibitors of HCV. Although 5-iodo derivative (7) was most inhibitory against HCV, it exhibited a reduction in cellular RNA levels in Huh-7 cells. The 5-hydroxymethyl-3'-fluoro-2',3'-dideoxyuridine (4) and 1-(3-chloro-2,3-dideoxy-β-d-erythro-pentofuranosyl)-5-fluorouracil (19) provided the most inhibition of both viruses without cytotoxicity.Copyright © 2010 Elsevier Ltd. All rights reserved.
相关化合物
相关文献:
2009-05-01
[J. Acquir. Immune Defic. Syndr. 51(1) , 54-9, (2009)]
1990-02-01
[Mol. Pharmacol. 37(2) , 157-63, (1990)]
1993-10-01
[Bioorg. Med. Chem. 1(4) , 279-84, (1993)]
2007-07-01
[Bioorg. Med. Chem. Lett. 17(13) , 3666-9, (2007)]
1989-02-01
[Appl. Environ. Microbiol. 55(2) , 419-24, (1989)]